OraSure Technologies - 39 Year Stock Price History | OSUR
Historical daily share price chart and data for OraSure Technologies since 1986 adjusted for splits and dividends. The latest closing stock price for OraSure Technologies as of June 12, 2025 is 2.93.
- The all-time high OraSure Technologies stock closing price was 27.00 on January 15, 1992.
- The OraSure Technologies 52-week high stock price is 4.92, which is 67.9% above the current share price.
- The OraSure Technologies 52-week low stock price is 2.36, which is 19.5% below the current share price.
- The average OraSure Technologies stock price for the last 52 weeks is 3.77.
| OraSure Technologies Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 3.3089 | 3.5400 | 4.1100 | 2.4300 | 2.9300 | -18.84% |
| 2024 | 5.1314 | 8.2800 | 8.2800 | 3.5800 | 3.6100 | -55.98% |
| 2023 | 5.9551 | 4.7900 | 8.3500 | 4.4000 | 8.2000 | 70.12% |
| 2022 | 5.2737 | 8.6600 | 9.3300 | 2.7100 | 4.8200 | -44.53% |
| 2021 | 10.6955 | 11.2100 | 15.4200 | 8.3000 | 8.6900 | -17.90% |
| 2020 | 11.7626 | 7.8900 | 19.5800 | 5.5700 | 10.5850 | 31.82% |
| 2019 | 9.1443 | 11.6700 | 13.0900 | 6.5700 | 8.0300 | -31.25% |
| 2018 | 16.3639 | 19.2900 | 22.0400 | 10.5300 | 11.6800 | -38.07% |
| 2017 | 15.7649 | 8.7900 | 22.8100 | 8.4800 | 18.8600 | 114.81% |
| 2016 | 7.2931 | 6.3500 | 9.3700 | 5.1800 | 8.7800 | 36.34% |
| 2015 | 6.3313 | 9.9500 | 10.5200 | 4.4400 | 6.4400 | -36.49% |
| 2014 | 7.7533 | 6.4700 | 10.5300 | 5.5300 | 10.1400 | 61.21% |
| 2013 | 5.4950 | 7.2500 | 7.3700 | 3.7900 | 6.2900 | -12.40% |
| 2012 | 10.0598 | 9.5100 | 13.3800 | 6.6900 | 7.1800 | -21.19% |
| 2011 | 8.0305 | 6.0100 | 9.9900 | 6.0100 | 9.1100 | 58.43% |
| 2010 | 4.8892 | 5.2900 | 6.7700 | 3.2500 | 5.7500 | 13.19% |
| 2009 | 3.1957 | 3.6600 | 5.1900 | 2.2500 | 5.0800 | 38.04% |
| 2008 | 5.3908 | 8.7200 | 9.1100 | 2.4300 | 3.6800 | -58.61% |
| 2007 | 8.5124 | 8.1500 | 10.5200 | 7.0400 | 8.8900 | 7.63% |
| 2006 | 8.8516 | 9.1200 | 11.5000 | 6.2500 | 8.2600 | -6.35% |
| 2005 | 8.8832 | 6.6000 | 13.9400 | 5.4300 | 8.8200 | 31.25% |
| 2004 | 7.6589 | 7.9200 | 10.5000 | 5.2000 | 6.7200 | -15.58% |
| 2003 | 7.7248 | 5.6400 | 10.7900 | 5.3800 | 7.9600 | 46.06% |
| 2002 | 5.9591 | 12.2000 | 12.2000 | 3.6500 | 5.4500 | -55.14% |
| 2001 | 10.1889 | 7.5313 | 14.7400 | 6.5000 | 12.1500 | 47.27% |
| 2000 | 10.8317 | 6.4375 | 17.0000 | 5.8750 | 8.2500 | 26.92% |
| 1999 | 5.6114 | 6.0000 | 7.8750 | 4.0000 | 6.5000 | 10.64% |
| 1998 | 5.3125 | 5.3750 | 6.8750 | 3.0000 | 5.8750 | 17.50% |
| 1997 | 8.7381 | 12.1250 | 16.2500 | 4.5000 | 5.0000 | -56.52% |
| 1996 | 15.5261 | 15.2500 | 21.5000 | 11.1250 | 11.5000 | -30.30% |
| 1995 | 15.5521 | 21.2500 | 21.2500 | 9.8750 | 16.5000 | -22.81% |
| 1994 | 18.1949 | 20.5000 | 24.8750 | 14.0000 | 21.3750 | 4.91% |
| 1993 | 19.4373 | 19.1250 | 23.6250 | 16.2500 | 20.3750 | 13.19% |
| 1992 | 19.6014 | 22.8750 | 27.0000 | 15.2500 | 18.0000 | -21.31% |
| 1991 | 17.6440 | 9.6250 | 26.0000 | 8.5000 | 22.8750 | 134.62% |
| 1990 | 7.2681 | 6.1250 | 9.8750 | 5.1250 | 9.7500 | 59.18% |
| 1989 | 6.5694 | 7.3750 | 9.6250 | 5.1250 | 6.1250 | -16.95% |
| 1988 | 7.7226 | 7.2500 | 10.1250 | 6.3750 | 7.3750 | 22.92% |
| 1987 | 7.5184 | 1.9375 | 11.7500 | 1.8333 | 6.0000 | 216.49% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.218B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.365B | 28.30 |
| Boston Scientific (BSX) | United States | $147.057B | 36.81 |
| Stryker (SYK) | United States | $145.454B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $130.907B | 0.00 |
| Medtronic (MDT) | Ireland | $112.941B | 16.01 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.659B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.106B | 27.97 |
| ResMed (RMD) | United States | $36.856B | 27.68 |
| Agilent Technologies (A) | United States | $34.008B | 22.17 |
| GE HealthCare Technologies (GEHC) | United States | $33.609B | 15.96 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.270B | 83.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.645B | 11.98 |
| Baxter (BAX) | United States | $16.114B | 12.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.196B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.264B | 21.80 |
| Lantheus Holdings (LNTH) | United States | $5.587B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.206B | 18.79 |
| Perrigo (PRGO) | Ireland | $3.763B | 9.54 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.435B | 15.65 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Envista Holdings (NVST) | United States | $3.259B | 27.08 |
| GN Store Nord (GNNDY) | Denmark | $2.362B | 19.57 |
| QuidelOrtho (QDEL) | United States | $2.094B | 14.40 |
| LeMaitre Vascular (LMAT) | United States | $1.878B | 41.99 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| Neogen (NEOG) | United States | $1.238B | 15.85 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| BioLife Solutions (BLFS) | United States | $1.128B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.075B | 24.19 |
| Kestra Medical Technologies (KMTS) | United States | $1.001B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.989B | 12.64 |
| InMode (INMD) | Israel | $0.903B | 9.10 |
| Evolus (EOLS) | United States | $0.660B | 0.00 |
| CeriBell (CBLL) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.606B | 5.03 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.340B | 60.40 |
| Canopy Growth (CGC) | Canada | $0.289B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| ZimVie (ZIMV) | United States | $0.265B | 12.06 |
| Cresco Labs (CRLBF) | United States | $0.261B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.09 |
| Verano Holdings (VRNOF) | United States | $0.183B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 16.05 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.61 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.21 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |